Reduced number of redundancies initially planned by the pharmaceutical company. The agreement focuses on voluntary exits and opens a new phase of comparison
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
Reduced number of redundancies initially planned by the pharmaceutical company. The agreement focuses on voluntary exits and opens a new phase of comparison